Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. (Q40453744)
Jump to navigation
Jump to search
scientific article published on February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. |
scientific article published on February 2005 |
Statements
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance (English)
Yoichi Nakamura
Mikio Oka
Ken Shiozawa
Megumi Yoshikawa
Akiko Itoh
Yoji Ikegami
Junji Tsurutani
Katsumi Nakatomi
Takeshi Kitazaki
Seiji Doi
Hisahiro Yoshida
1 February 2005